Company
Kiromic Biopharma, Inc. (0001792581)
Standardized SEC financial data for Kiromic Biopharma, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001792581 · Biological Products, (No Diagnostic Substances).
Return on equity
268.0%
Free cash flow
-$19.8M
Current ratio
0.16×
EPS (diluted)
$-12.59
Income statement
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| R&D expense | $1.2M | $5.1M | $11.4M | $13.9M | $6.9M | $6.9M |
| SG&A expense |
Balance sheet
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.9M | $10.2M | $25.4M | $645K | $3.2M | $1.8M |
| Inventory |
Cash flow
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$2.9M | -$6.1M | -$20.3M | -$23.7M | -$21.2M | -$19.5M |
| Capital expenditures |
Get 0001792581 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001792581/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001792581/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"